Boiron USA (BOI): aksiya narxi va yangiliklar

BOI:EPA

Boiron USA

19,60 €

+0,51%

(+0,10) 1K

6-noy, 15:03:34 (GMT+1) · EUR

Barcha belgilar

	Belgi	Narxi	Oʻzgartirishlar	Dinamika (%)

BOI tikeri uchun statistika yaratilmoqda...

Ochish

19,90 €

Yuqori

19,90 €

Past

19,25 €

Bozor kapitali

343,89 mln

Oʻrtacha hajm

4,95 ming

Hajmi

2,48 ming

P/E koeffitsiyenti

12,99

52 haftalik eng yuqori

32,25 €

52 haftalik eng past

16,90 €

Aksiya boʻyicha daromad

1,51 €

Muomaladagi aksiyalar

17,55 mln

Xodimlar soni

3 ming

Ochish

19,90 €

Yuqori

19,90 €

Past

19,25 €

Bozor kapitali

343,89 mln

Oʻrtacha hajm

4,95 ming

Hajmi

2,48 ming

P/E koeffitsiyenti

12,99

52 haftalik eng yuqori

32,25 €

52 haftalik eng past

16,90 €

Aksiya boʻyicha daromad

1,51 €

Muomaladagi aksiyalar

17,55 mln

Xodimlar soni

3 ming

Aloqador aksiyalar

Bank of East Asia Ltd

Yangiliklar

Internet manbalari va yangilik hamkorlarimizdan

Spectrum News

22 soat oldin

S&P 500 drops 4.4% in worst day since 2025 as AI chips slide

Barron's

2 soat oldin

S&P 500 Futures Rise in Premarket Trading; JFrog, Cloudflare Lead

MarketWatch

2 soat oldin

The S&P 500’s most reliable dividend stocks are beating the market. Here’s how to play them.

Yahoo Finance

3 soat oldin

iShares Core S&P 500 (IVV) Buys $394.7 Million More Oracle on Nov. 4

Profil

Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index. In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations. Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs". Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia

Boiron USA haqida

CEO-

Xodimlar soni2,62 ming

Asos solingan7-iyn, 1932

Bosh ofislar-

SektorHealth Care

Soha-

Veb-saytboiron.fr

Barcha qiymatlar – EUR	sen, 2025	dek, 2025	mar, 2026	iyn, 2026
Daromad	127,73 mln	127,73 mln	120,16 mln	120,16 mln
Sotilgan mahsulotning tannarxi	35,40 mln	35,40 mln	33,53 mln	33,53 mln
Daromad narxi	35,40 mln	35,40 mln	33,53 mln	33,53 mln
Tadqiqot va ishlanmalarga xarajatlar	1,56 mln	1,56 mln	1,44 mln	1,44 mln
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar	-	-	-	-
Tijoriy, umumiy va maʼmuriy xarajatlar	79,26 mln	79,26 mln	79,95 mln	79,95 mln
Operatsion xarajatlar	77,52 mln	77,52 mln	81,88 mln	81,88 mln
Jami operatsion xarajatlar	112,92 mln	112,92 mln	115,41 mln	115,41 mln
Operatsion daromad	14,81 mln	14,81 mln	4,76 mln	4,76 mln
Boshqa nooperatsion daromad	-1,13 mln	-1,13 mln	-2,29 mln	-2,29 mln
Soliq toʻlangunga qadar foyda, shu jumladan gʻayrioddiy moddalar	13,82 mln	13,82 mln	4,02 mln	4,02 mln
Soliq toʻlangunga qadar foyda, gʻayrioddiy moddalar bundan mustasno	13,16 mln	13,16 mln	2,75 mln	2,75 mln
Daromad soligʻi boʻyicha xarajat	3,18 mln	3,18 mln	1,56 mln	1,56 mln
Amaldagi soliq stavkasi	22,99%	22,99%	38,90%	38,90%
Boshqa operatsion xarajatlar	-3,30 mln	-3,30 mln	488,00 ming	488,00 ming
Sof foyda	10,64 mln	10,64 mln	2,46 mln	2,46 mln
Sof foyda marjasi	8,33%	8,33%	2,04%	2,04%
Har bir aksiya foydasi	-	-	-	-
Foizlar va investitsiyalardan olingan daromadlar	653,00 ming	653,00 ming	636,50 ming	636,50 ming
Foizlarni toʻlash xarajatlari	-335,00 ming	-335,00 ming	-410,00 ming	-410,00 ming
Foizlarni toʻlash boʻyicha sof xarajatlar	318,00 ming	318,00 ming	226,50 ming	226,50 ming
Amortizatsiya ajratmalari	-	-	-	-
EBITDA	18,06 mln	18,06 mln	11,17 mln	11,17 mln
Aktivlarni sotishdan olingan foyda yoki zarar	-446,00 ming	-446,00 ming	-	-

Savol bering